Archives

  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2021-03
  • 2020-08
  • 2020-07
  • 2020-03
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • b iframe width height src https www

    2022-07-25

    r> Although generation of ROS is essential to p53-expression, cells un-dergoing p53-mediated apoptosis also generated ROS (Johnson et al., 1996). In fact, it has been reported that aberrant ROS-generation medi-ates p53-activation and apoptosis in HeLa cells. Interestingly, treatment of those cells with two antioxidants, N-acetylcysteine (NAC) and 4,5-di-hydroxy-1,3-benzenedisulfonic EPZ-6438 (tiron) significantly reduced the expression of p53 (Li, 1999).
    Taken together, these results indicate that the treatment induced both extrinsic and intrinsic apoptosis pathways and are inaccordance with previous study on KB human oral cancer cells treated with berber-ine (Kim et al., 2015).
    4. Conclusion
    Many studies showed that the use of medicinal plant extracts to con-trol or stop cancer progression should be an alternative to conventional treatment for this disease. In this work we demonstrated the antiprolif-erative effect of Algerian Berberis hispanica alkaloids extract on Hep-2 cancer cells and its ability to induce cell death through ROS-generation leading to morphological and molecular modifications, cell cycle arrest and induction of apoptosis. The results obtained open up prospects for a possible combination of this compound with existent anticancer drug already existing.
    Conflict of interest
    There are no conflicts of interests.
    References
    Bruneton, J., 1999. Généralités, in: Pharmacognosie, phytochimie, plantes médicinales.
    Dhamgaye, S., Devaux, F., Vandeputte, P., Khandelwal, N.K., Sanglard, D., Mukhopadhyay, G., Prasad, R., 2014. Molecular mechanisms of action of herbal antifungal alkaloid Ber-berine, in Candida albicans. PLoS One 9, e104554. Du, J., 2017. Berberine and evodiamine act synergistically against human breast cancer MCF-7 cells by inducing cell cycle arrest and apoptosis. Anticancer Res. 37.
    Havelek, R., Seifrtova, M., Kralovec, K., Bruckova, L., Cahlikova, L., Dalecka, M., Vavrova, J., Rezacova, M., Opletal, L., Bilkova, Z., 2014. The effect of Amaryllidaceae alkaloids haemanthamine and haemanthidine on cell cycle progression and apoptosis in p53-negative human leukemic Jurkat cells. Phytomedicine 21, 479–490.
    Heath, R.L., Packer, L., 1968. Photoperoxidation in isolated chloroplasts. Arch. Biochem.
    Iizuka, N., 2000. Inhibitory effect of coptidis rhizoma and berberine on the proliferation of human esophageal cancer cell lines. Cancer Lett. 148, 19–25. Imanshahidi, M., Hosseinzadeh, H., 2008. Pharmacological and therapeutic effects of Ber-beris vulgaris and its active constituent, berberine. Phytother. Res. 22, 999–1012. International Agency for Research on Cancer, World Health Organization, 2014. Latest World Cancer Statistics Global Cancer Burden Rises to 14.1 million New Cases in 2012: Marked Increase in Breast and Cervix Cancers must be Addressed (press report no. 223). World Health Organization https://www.iarc.fr/wp-content/uploads/2018/ 07/pr223_E.pdf.
    Ivanovska, N., Philipov, S., 1996. Study on the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids. Int. J. Immunopharmacol. 18, 553–561.
    Kutchan, T.M., 1995. Alkaloid biosynthesis—the basis for metabolic engineering of medic-inal plants. Plant Cell Online 7, 1059–1070.
    Li, P.-F., 1999. p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J. 18, 6027–6036.
    Mantena, S.K., 2006. Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol. Cancer Ther. 5, 296–308.
    Meeran, S.M., Katiyar, S., Katiyar, S.K., 2008. Berberine-induced apoptosis in human pros-tate cancer cells is initiated by reactive oxygen species generation. Toxicol. Appl. Pharmacol. 229, 33–43.